Skip to main content

Table 1 Baseline characteristics of 300 patients with chronic hepatitis B, Addis Ababa, Ethiopia

From: Early experiences from one of the first treatment programs for chronic hepatitis B in sub-Saharan Africa

Characteristics

Number (%)

Sex

 Male

162 (54.0)

 Female

138 (46.0)

Age group (years)

 18–25

65 (21.7)

 26–35

129 (43.0)

 36–45

60 (20.0)

  > 45

46 (15.3)

Marital status

 Single

104 (34.7)

 Married

185 (61.7)

 Divorced/widowed

11 (3.6)

Previous antiviral treatment

 Yes

29 (9.7)

 No

271 (90.3)

Substance abuse

 Alcohol

5 (1.7)

 Khat

18 (6.0)

Fasting TE value (kPa) (n = 268)

  ≤ 7.9

189 (70.5)

 8.0–9.9

29 (10.8)

  > 9.9

50 (18.7)

ALT (U/L) (n = 295)

  ≤ 40

245 (83.1)

 41–80

34 (11.5)

  > 80

16 (5.4)

HBeAg (n = 289)

 Positive

27 (9.3)

 Negative

262 (90.7)

HBV viral load (IU/ml) (n = 294)

  < 2000

169 (57.5)

 2000–20,000

60 (20.4)

  ≥ 20,000

65 (22.1)

HBV genotype (n = 79)

 A

67 (84.8)

 D

12 (15.2)

Co-infections

 HIV

5 (1.7)

 HCV

4 (1.3)

 HDV (n = 294)

11 (3.7)

  1. TE transient elastography, ALT alanine aminotransferase, HBeAg hepatitis B e-antigen, HBV hepatitis B virus, HIV human immunodeficiency virus, HCV hepatitis C virus, HDV hepatitis D virus